LOS ANGELES--(BUSINESS WIRE)--
Catasys, Inc. (CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to participate in two upcoming investor conferences in March, including the 31st Annual ROTH Conference in Laguna Niguel, California and the Oppenheimer 29th Annual Healthcare Conference in New York City. Management will hold one-on-one meetings with investors during the conferences.
Details on the two events are below.
31st Annual Roth Capital Partners Conference – March 18-19, 2019 (Laguna Niguel, CA)
The Company will participate in the 31st Annual ROTH Capital Partners Conference, which will be held March 18 – 19, 2019 at the Ritz-Carlton in Dana Point, California. The Company will have a pre-recorded presentation available for remote viewing via http://wsw.com/webcast/roth33/cats.
In addition, Mr. Peizer will join a panel discussion on “Behavioral Health and Substance Use Disorder” at 10:00 a.m. Pacific Time on Monday, March 18, 2019.
Oppenheimer & Co. 29th Annual Healthcare Conference (New York City)
The Company also will present at Oppenheimer's 29th Annual Healthcare Conference to be held in New York, NY on March 19 – 20, 2019.
Catasys will present on Wednesday, March 20, 2019 at 2:45 p.m. Eastern Time. A webcast of the presentation will be available in the Investors section of the Company's website, and also at https://www.veracast.com/webcasts/opco/healthcare2019/67214651580.cfm.
About Catasys, Inc.
Catasys, Inc. harnesses proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives.
Catasys' OnTrak solution--contracted with a growing number of national and regional health plans--is designed to treat members with behavioral conditions that cause or exacerbate co-existing medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs.
Catasys has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance matched with data driven engagement technologies.
OnTrak integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient solution. The program is currently improving member health and, at the same time, is demonstrating reduced inpatient and emergency room utilization, driving a more than 50 percent reduction in total health insurers' costs for enrolled members. OnTrak is available to members of several leading health plans in California, Connecticut, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, Nebraska, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin.